Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

被引：182

作者：

Yuan, Xun ^{[1
]}

Wu, Hua ^{[1
]}

Han, Na ^{[1
]}

Xu, Hanxiao ^{[1
]}

Chu, Qian ^{[1
]}

Yu, Shiying ^{[1
]}

Chen, Yuan ^{[1
]}

Wu, Kongming ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Bldg 303,1095 Jie Fang Ave, Wuhan 430030, Peoples R China

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2014年 / 7卷

基金：

美国国家科学基金会;

关键词：

Notch signaling; Epithelial-mesenchymal transition (EMT); Cancer stem cells (CSCs); Non-small-cell lung cancer (NSCLC); Gamma secretase inhibitor; EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-SECRETASE INHIBITOR; CYCLIN D1; TGF-BETA; POOR-PROGNOSIS; TUMOR-GROWTH; STEM-CELLS; E-CADHERIN; IN-VITRO; PHASE-I;

D O I：

10.1186/s13045-014-0087-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Through epithelial-mesenchymal transition (EMT), cancer cells acquire enhanced ability of migration and invasion, stem cell like characteristics and therapeutic resistance. Notch signaling regulates cell-cell connection, cell polarity and motility during organ development. Recent studies demonstrate that Notch signaling plays an important role in lung cancer initiation and cross-talks with several transcriptional factors to enhance EMT, contributing to the progression of non-small cell lung cancer (NSCLC). Correspondingly, blocking of Notch signaling inhibits NSCLC migration and tumor growth by reversing EMT. Clinical trials have showed promising effect in some cancer patients received treatment with Notch1 inhibitor. This review attempts to provide an overview of the Notch signal in NSCLC: its biological significance and therapeutic application.

引用

页数：10

共 50 条

[21] The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions
Mu Hu
Lin Ye
Fiona Ruge
Xiuyi Zhi
Lijian Zhang
Wen G Jiang
BMC Cancer, 12
[22] The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions
Hu, Mu
Ye, Lin
Ruge, Fiona
Zhi, Xiuyi
Zhang, Lijian
Jiang, Wen G.
BMC CANCER, 2012, 12
[23] Clinical Significance and Biological Function of miR-1274a in Non-small Cell Lung Cancer
Zhu, Shi-jia
Wang, Xiao
Hu, Song-liu
Fang, Yu
Guan, Bi-xi
Li, Jian
Li, Gen
Xu, Jian-yu
MOLECULAR BIOTECHNOLOGY, 2022, 64 (01) : 9 - 16
[24] The Biological and Clinical Significance of Alpha-1 Antitrypsin in Non-Small Cell Lung Cancer
Szpechcinski, Adam
Chorostowska-Wynimko, Joanna
Langfort, Renata
Debek, Emilia
Kupis, Wlodzimierz
Rudzinski, Piotr
Zaleska, Jolanta
Poplawska-Wisniewska, Beata
Struniawski, Radoslaw
Giedronowicz, Dorota
Orlowski, Tadeusz
Roszkowski-Sliz, Kazimierz
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S712 - S712
[25] Clinical Significance and Biological Function of miR-1274a in Non-small Cell Lung Cancer
Shi-jia Zhu
Xiao Wang
Song-liu Hu
Yu Fang
Bi-xi Guan
Jian Li
Gen Li
Jian-yu Xu
Molecular Biotechnology, 2022, 64 : 9 - 16
[26] The clinical significance of osteopontin (OPN) in non-small cell lung cancer and its biological impact on lung cancer cells
Hao, C.
Cui, Y.
Hu, M.
Zhi, X.
Cheng, S.
Jiang, W. G.
EUROPEAN JOURNAL OF CANCER, 2017, 72 : S182 - S182
[27] Bronchoscopy Diagnostic and Therapeutic for Non-Small Cell Lung Cancer
Bauer, Thomas L.
Berkheim, David B.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 481 - +
[28] Therapeutic options for oligoprogressive non-small cell lung cancer
Gustin, P.
Botticella, A.
Tselikas, L.
Mercier, O.
Le Pechoux, C.
Levy, A.
REVUE DES MALADIES RESPIRATOIRES, 2019, 36 (04) : 519 - 526
[29] Molecular therapeutic targets in non-small cell lung cancer
Sankar, Kamya
Gadgeel, Shirish M.
Qin, Angel
EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (08) : 647 - 661
[30] Therapeutic vaccines for advanced non-small cell lung cancer
Cortes-Jofre, Marcela
Rueda-Etxebarria, Mikel
Orillard, Emeline
Jimenez Tejero, Elena
Rueda, Jose-Ramon
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (03):

← 1 2 3 4 5 →